Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
about
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerImportance of relating efficacy measures to unbound drug concentrations for anti-infective agentsPopulation pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.Linezolid for the treatment of drug-resistant infections.Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model.Adipocyte, adipose tissue, and infectious disease.Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model.Antimicrobial dosing considerations in obese adult patients.Linezolid: effectiveness and safety for approved and off-label indications.Reply to "Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient".Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.Basis for selecting optimum antibiotic regimens for secondary peritonitis.Pharmacokinetics of linezolid in critically ill patients.Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro InformationClinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysis.Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.Penetration of linezolid into synovial fluid and muscle tissue after elective arthroscopy.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.
P2860
Q26825326-B5D9C78B-6803-4402-AC8C-52F89D08FC70Q26827380-3BD444A8-47B6-4E4A-82B0-1E235B5E6C5AQ33439246-C8F411F4-03F8-424F-8AB3-D070CEE9DD61Q34274190-EBFEE617-53D2-4AD5-BDFF-3E0A8AABFC97Q34894133-51E7D675-F03D-4C56-878E-F552670507ACQ34923002-94654D3F-8042-43FE-B731-F4A1DBC6F33DQ35689443-B44D79FE-976D-491D-A83F-3DE476E3A301Q35959546-BF626673-7E61-41B8-9977-6B4DDBBDF0D2Q36083208-3BADE095-11F8-4B87-B4CD-EBBB2D0E6ED0Q36171683-A42C9949-081E-4480-B14C-3E1B399526ACQ36892796-3C8DCBDE-EB92-4804-9AEE-F62A0B3FE5DFQ36967288-D7BC282B-76AA-478D-8306-3784D6132E68Q37335675-CC78154B-E72E-4966-B0B5-5A5C67BFF8B6Q37869258-8F0C07BD-F570-4AB7-9389-BD20ED730821Q38058355-6CB5BC45-3C2C-4811-B361-5C424D90DC58Q38283321-2A62F9FB-73C2-47DD-9D6D-4F5D42373FBEQ38633450-75372145-6924-4DBF-8F9E-10205AE7D3F2Q38791528-C65094DB-2B42-4498-A9B6-40A2A683EC56Q38853629-B42B9514-3128-47C3-9934-79689E256E1CQ39278957-590FEB88-2A42-4A9E-A54A-78F8FC72BE8BQ39715575-77BF25E4-C4EC-4A6A-9395-A940FA152CD6Q41077233-54D8454F-3026-48AB-B4EA-73A324BBF20BQ42149011-D4BE370B-AA11-4625-ACB2-E4D34115E5D4Q46837532-FDBF5403-976A-4D15-B3EC-1E6CA1D74323Q47218572-C0397A22-3215-4C7B-B9F2-FE2FB0DC1C66Q47236135-560A869D-0502-4E57-82B7-F2976B9D336AQ47611899-E8328EC3-83D7-4AD7-B5CA-71B61A6C9564Q51423932-92B8601B-37DC-43FD-8CBB-3F2B7B573639
P2860
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacokinetics of unbound li ...... le dosing using microdialysis.
@en
type
label
Pharmacokinetics of unbound li ...... le dosing using microdialysis.
@en
prefLabel
Pharmacokinetics of unbound li ...... le dosing using microdialysis.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of unbound li ...... le dosing using microdialysis.
@en
P2093
Charlotte Kloft
Christian Joukhadar
Cornelia Buerger
Nele Plock
Pejman Dehghanyar
P2860
P304
P356
10.1128/AAC.01468-05
P407
P577
2006-07-01T00:00:00Z